Deciphera Pharmaceuticals, Inc. Patent Applications Rejected
19 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2022-06-21: Application 17845278; Invention USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA; Applicant Deciphera Pharmaceuticals, LLC; Status Abandoned -- After Examiner's Answer or Board of Appeals Decision.
- 2022-05-03: Application 17735784; Invention AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF; Applicant Deciphera Pharmaceuticals, LLC; Status Abandoned -- Failure to Respond to an Office Action.
- 2022-05-03: Application 17735741; Invention AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF; Applicant Deciphera Pharmaceuticals, LLC; Status Abandoned -- Failure to Respond to an Office Action.
- 2021-11-24: Application 17534771; Invention ANTI-VIRAL ACTIVITY OF VPS34 INHIBITORS; Applicant Deciphera Pharmaceuticals, LLC; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2022-06-21 | 17845278 | USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA | Deciphera Pharmaceuticals, LLC | Abandoned -- After Examiner's Answer or Board of Appeals Decision | US20220370424A1 | Daniel L. Flynn Michael D. Kaufman Oliver Rosen Bryan D. Smith | United States United States United States United States | RODRIGUEZ, RAYNA B |
| 2022-05-03 | 17735784 | AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF | Deciphera Pharmaceuticals, LLC | Abandoned -- Failure to Respond to an Office Action | US20220265623A1 | Michael D. Kaufman Scott Bone Corey Bloom Fred Jordan | United States United States United States United States | TRAN, SUSAN T |
| 2022-05-03 | 17735741 | AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF | Deciphera Pharmaceuticals, LLC | Abandoned -- Failure to Respond to an Office Action | US20220265622A1 | Michael D. Kaufman Scott Bone Corey Bloom Fred Jordan | United States United States United States United States | TRAN, SUSAN T |
| 2021-11-24 | 17534771 | ANTI-VIRAL ACTIVITY OF VPS34 INHIBITORS | Deciphera Pharmaceuticals, LLC | Abandoned -- Failure to Respond to an Office Action | US20220184093A1 | Daniel L. Flynn | United States | ABDALHAMEED, MANAHIL MIRGHANI ALI |
| 2021-11-24 | 17534769 | ANTI-VIRAL ACTIVITY OF VPS34 INHIBITORS | Deciphera Pharmaceuticals, LLC | Abandoned -- Failure to Respond to an Office Action | US20220184077A1 | Daniel L. Flynn | United States | ROZOF, TIMOTHY R |
| 2021-11-24 | 17534764 | ANTI-VIRAL ACTIVITY OF VPS34 INHIBITORS | Deciphera Pharmaceuticals, LLC | Abandoned -- Failure to Respond to an Office Action | US20220184054A1 | Daniel L. Flynn | United States | KENYON, JOHN S |
| 2021-11-24 | 17534762 | ANTI-VIRAL ACTIVITY OF VPS34 INHIBITORS | Deciphera Pharmaceuticals, LLC | Abandoned -- Failure to Respond to an Office Action | US20220184092A1 | Daniel L. Flynn | United States | KIFLE, BRUCK |
| 2021-10-21 | 17506772 | USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA | Deciphera Pharmaceuticals, LLC | Abandoned -- Failure to Respond to an Office Action | US20220031678A1 | Daniel L. Flynn Michael D. Kaufman Oliver Rosen Bryan D. Smith | United States United States United States United States | KANTAMNENI, SHOBHA |
| 2021-03-05 | 17193707 | METHODS OF USING REBASTINIB IN THE TREATMENT OF DISORDERS | Deciphera Pharmaceuticals, LLC | Abandoned -- Failure to Respond to an Office Action | US20210275518A1 | Rodrigo Ruiz Soto Keisuke Kuida Haroun Achour | United States United States United States | KISHORE, GOLLAMUDI S |
| 2020-09-22 | 17028591 | USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA | Deciphera Pharmaceuticals, LLC | Abandoned -- Failure to Respond to an Office Action | US20210015801A1 | Daniel L. Flynn Michael D. Kaufman Oliver Rosen Bryan D. Smith | United States United States United States United States | KANTAMNENI, SHOBHA |
| 2019-11-27 | 16617721 | USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA | Deciphera Pharmaceuticals, LLC | Abandoned -- Failure to Respond to an Office Action | US20200129489A1 | Daniel L. Flynn Michael D. Kaufman Oliver Rosen Bryan D. Smith | United States United States United States United States | RODRIGUEZ, RAYNA B |
| 2018-04-19 | 15957888 | METHODS FOR INHIBITING TIE-2 KINASE USEFUL IN THE TREATMENT OF CANCER | Deciphera Pharmaceuticals, LLC | Abandoned -- Failure to Respond to an Office Action | US20190091217A1 | Daniel L. FLYNN Michael D. KAUFMAN Bryan D. SMITH Marc RUDOLTZ | United States United States United States United States | RODRIGUEZ, RAYNA B |
| 2016-08-31 | 15253279 | METHODS FOR INHIBITING TIE-2 KINASE USEFUL IN THE TREATMENT OF CANCER | DECIPHERA PHARMACEUTICALS, LLC | Abandoned -- Failure to Respond to an Office Action | US20170209428A1 | Daniel L. Flynn Michael D. Kaufman Brian D. Smith Marc Rudoltz | United States United States United States United States | HUFF, SHEELA JITENDRA |
| 2015-10-14 | 14883109 | INHIBITION OF TUMOR CELL INTERACTIONS WITH THE MICROENVIRONMENT RESULTING IN A REDUCTION IN TUMOR GROWTH AND DISEASE PROGRESSION | Deciphera Pharmaceuticals, LLC | Abandoned -- Failure to Respond to an Office Action | US20170079966A1 | Daniel L. FLYNN Michael D. KAUFMAN Bryan D. SMITH | United States United States United States | LUNDGREN, JEFFREY S |
| 2015-10-14 | 14883072 | INHIBITION OF TRK KINASE MEDIATED TUMOR GROWTH AND DISEASE PROGRESSION | DECIPHERA PHARMACEUTICALS, LLC | Abandoned -- Failure to Respond to an Office Action | US20160101090A1 | Daniel L. FLYNN Michael D. KAUFMAN Bryan D. SMITH | United States United States United States | SIMMONS, CHRIS E |
| 2015-08-03 | 14816833 | IMIDAZOLIDINONES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES | Deciphera Pharmaceuticals, LLC | Abandoned -- Failure to Respond to an Office Action | US20160046619A1 | Daniel L. Flynn Michael D. Kaufman Thiwanka Samarakoon Timothy Malcolm Caldwell Lakshminarayana Vogeti YuMi Ahn William C. Patt Karen M. Yates | United States United States United States United States United States United States United States United States | REESE, HEIDI L |
| 2015-01-22 | 14602781 | CYCLOPROPYL DICARBOXAMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES | Deciphera Pharmaceuticals, LLC | Abandoned -- Failure to Respond to an Office Action | US20150218130A1 | Daniel L. Flynn Michael D. Kaufman | United States United States | BALASUBRAMANIAN, VENKATARAMAN |
| 2014-12-04 | 14560809 | DIHYDRONAPHTHYRIDINES AND RELATED COMPOUNDS USEFUL AS KINASE INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES | Deciphera Pharmaceuticals, LLC | Abandoned -- Failure to Respond to an Office Action | US20150320759A1 | Daniel L. Flynn Michael D. Kaufman Peter A. Petillo | United States United States United States | RAHMANI, NILOOFAR |
| 2013-12-20 | 14136295 | CYCLOPROPYL DICARBOXAMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES | Deciphera Pharmaceuticals, LLC | Abandoned -- Failure to Respond to an Office Action | US20140194405A1 | Daniel L. Flynn Michael D. Kaufman | United States United States | BALASUBRAMANIAN, VENKATARAMAN |